-
Electronic (PDF)
-
Hard Copy
-
CD ROM
-
Site License
-
Enterprisewide
Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2012
Fore Pharma, October 2012, Pages: 24
Fore Pharma announced the results of its Multiple Myeloma patient population study in a new report ‘Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2012’. The report provides insights into Multiple Myeloma epidemiology, Multiple Myeloma diagnosed patients, and Multiple Myeloma treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Multiple Myeloma derived from epidemiological analysis, percentage of patients diagnosed with Multiple Myeloma, and percentage of patients treated with Multiple Myeloma therapy.
The study helps executives estimate Multiple Myeloma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Multiple Myeloma prevalence, Multiple Myeloma diagnosis rate, and Multiple Myeloma treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- Multiple Myeloma: Disease Definition
- Multiple Myeloma Patient Flow
- Multiple Myeloma Prevalence
- Multiple Myeloma Diagnosed Patients
- Multiple Myeloma Treated Patients
1. Multiple Myeloma: Disease Definition
2. Global Multiple Myeloma Patient Flow
2A. Global Multiple Myeloma Prevalence
2B. Global Multiple Myeloma Diagnosed Patients
2C. Global Multiple Myeloma Treated Patients
3. Multiple Myeloma Patient Flow in the US
3A. Multiple Myeloma Prevalence in the US
3B. Multiple Myeloma Diagnosed Patients in the US
3C. Multiple Myeloma Treated Patients in the US
4. Multiple Myeloma Patient Flow in Europe
4A. Multiple Myeloma Prevalence in Europe
4B. Multiple Myeloma Diagnosed Patients in Europe
4C. Multiple Myeloma Treated Patients in Europe
5. Multiple Myeloma Patient Flow in Germany
5A. Multiple Myeloma Prevalence in Germany
5B. Multiple Myeloma Diagnosed Patients in Germany
5C. Multiple Myeloma Treated Patients in Germany
6. Multiple Myeloma Patient Flow in France
6A. Multiple Myeloma Prevalence in France
6B. Multiple Myeloma Diagnosed Patients in France
6C. Multiple Myeloma Treated Patients in France
7. Multiple Myeloma Patient Flow in Spain
7A. Multiple Myeloma Prevalence in Spain
7B. Multiple Myeloma Diagnosed Patients in Spain
7C. Multiple Myeloma Treated Patients in Spain
8. Multiple Myeloma Patient Flow in Italy
8A. Multiple Myeloma Prevalence in Italy
8B. Multiple Myeloma Diagnosed Patients in Italy
8C. Multiple Myeloma Treated Patients in Italy
9. Multiple Myeloma Patient Flow in UK
9A. Multiple Myeloma Prevalence in UK
9B. Multiple Myeloma Diagnosed Patients in UK
9C. Multiple Myeloma Treated Patients in UK
10. Multiple Myeloma Patient Flow in Japan
10A. Multiple Myeloma Prevalence in Japan
10B. Multiple Myeloma Diagnosed Patients in Japan
10C. Multiple Myeloma Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources
Table 1: Global Multiple Myeloma Patient Flow (2012)
Table 2: Global Multiple Myeloma Patient Flow Forecast (2012-2019)
Table 3: Multiple Myeloma Patient Flow in the US (2012)
Table 4: Multiple Myeloma Patient Flow Forecast in the US (2012-2019)
Table 5: Multiple Myeloma Patient Flow in Europe (2012)
Table 6: Multiple Myeloma Patient Flow Forecast in Europe (2012-2019)
Table 7: Multiple Myeloma Patient Flow in Germany (2012)
Table 8: Multiple Myeloma Patient Flow Forecast in Germany (2012-2019)
Table 9: Multiple Myeloma Patient Flow in France (2012)
Table 10: Multiple Myeloma Patient Flow Forecast in France (2012-2019)
Table 11: Multiple Myeloma Patient Flow in Spain (2012)
Table 12: Multiple Myeloma Patient Flow Forecast in Spain (2012-2019)
Table 13: Multiple Myeloma Patient Flow in Italy (2012)
Table 14: Multiple Myeloma Patient Flow Forecast in Italy (2012-2019)
Table 15: Multiple Myeloma Patient Flow in UK (2012)
Table 16: Multiple Myeloma Patient Flow Forecast in UK (2012-2019)
Table 17: Multiple Myeloma Patient Flow in Japan (2012)
Table 18: Multiple Myeloma Patient Flow Forecast in Japan (2012-2019)
Figure 1: Global Multiple Myeloma Patient Flow (2012)
Figure 2: Global Multiple Myeloma Patient Flow Forecast (2012-2019)
Figure 3: Multiple Myeloma Patient Flow in the US (2012)
Figure 4: Multiple Myeloma Patient Flow Forecast in the US (2012-2019)
Figure 5: Multiple Myeloma Patient Flow in Europe (2012)
Figure 6: Multiple Myeloma Patient Flow Forecast in Europe (2012-2019)
Figure 7: Multiple Myeloma Patient Flow in Germany (2012)
Figure 8: Multiple Myeloma Patient Flow Forecast in Germany (2012-2019)
Figure 9: Multiple Myeloma Patient Flow in France (2012)
Figure 10: Multiple Myeloma Patient Flow Forecast in France (2012-2019)
Figure 11: Multiple Myeloma Patient Flow in Spain (2012)
Figure 12: Multiple Myeloma Patient Flow Forecast in Spain (2012-2019)
Figure 13: Multiple Myeloma Patient Flow in Italy (2012)
Figure 14: Multiple Myeloma Patient Flow Forecast in Italy (2012-2019)
Figure 15: Multiple Myeloma Patient Flow in UK (2012)
Figure 16: Multiple Myeloma Patient Flow Forecast in UK (2012-2019)
Figure 17: Multiple Myeloma Patient Flow in Japan (2012)
Figure 18: Multiple Myeloma Patient Flow Forecast in Japan (2012-2019)
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
